Abeona Therapeutics Inc. Quarterly report pursuant to Section 13 or 15(d)

OPERATING LEASES (Tables)

6 Months Ended

Jun. 30, 2019

Components of lease cost are as follows:

The following table presents information about the amount and timing of cash flows arising from operating leases as of June 30, 2019:


Maturity of lease liabilities:
2019, remainder	$	845,000
2020		1,699,000
2021		1,713,000
2022		1,727,000
2023		1,741,000
Thereafter		3,667,000
Total undiscounted operating lease payments		11,392,000
Less: imputed interest		2,991,000
Present value of operating lease liabilities	$	8,401,000

Balance sheet classification:
Current portion of lease liability	$	1,693,000
Long-term lease liability		6,708,000
Total operating lease liabilities	$	8,401,000

Other information:
Weighted-average remaining lease term for operating leases		79 months
Weighted-average discount rate for operating leases		9.6	%